Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer

D Dongdong Zheng J Jiaqi Yan (School of Engineering and Applied Sciences, Harvard University) X Xuejiao Liu Z Zhiming Zhang (State Key Laboratory of Vegetation Structure, Function and Construction (VegLab) and School of Ecology and Environmental Sciences, Yunnan University) A Anqi Jin Y Yue Zhao L Lu Bai (Beijing Key Laboratory of Solid-State Battery and Energy Storage Process, Key Laboratory of Green Process and Engineering, State Key Laboratory of Mesoscience and Process Engineering) M Mengyao Quan (Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China) X Xiuzhu Qi (Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China) B Bin Fu (State Key Laboratory of Medical Proteomics) Z Zhigang Wu (Taizhou Research Institute) J Jin Zhou (Department of Oncology Sichuan Cancer Hospital Chengdu China) H Han Han (Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States) Z Ziqi Wang (Division of Advanced Materials) S Shiyu Wang C Chaoqiang Deng (Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering Shanghai 200032 P. R. China) W Weijian Sun C Cai Chang (Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China) S Shichong Zhou H Hongbo Zhang

Abstract

Abstract Cancer‐associated fibroblasts (CAFs) play a pivotal role in inducing photothermal therapy (PTT) resistance of triple‐negative breast cancer (TNBC), but with unclear mechanism. Herein, aminoethyl anisamide‐modified nano‐biomimetic low‐density lipoprotein (A‐aLDL) is used to target deliver the PTT agent and artesunate (ARS) to both CAFs and cancer cells. Though CAFs are sensitive to PTT and notably transition to heat‐resistant phenotype, the formed protective barrier is destroyed by ARS. Subsequently, the outstanding anti‐tumor effects are achieved through PTT in multiple models with such kind of combination therapy. Interestingly, the mechanism is discovered that serine metabolism plays a major role in CAF resistance through spatially omics. ARS disrupts serine homeostasis, thereby attenuating the cascade activity of GTPases in MAPK pathway. Meanwhile, MAP2K7 is the most potential target for sensitizing PTT. By integrating ARS with PTT agents, the serine‐MAPK axis in CAFs is successfully modulated, thereby overcoming PTT resistance in TNBC therapy.

Article Details

Volume / Issue Vol. 37, Issue 35
Published September 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (20)

D

Dongdong Zheng

J

Jiaqi Yan

School of Engineering and Applied Sciences, Harvard University

X

Xuejiao Liu

Z

Zhiming Zhang

State Key Laboratory of Vegetation Structure, Function and Construction (VegLab) and School of Ecology and Environmental Sciences, Yunnan University

A

Anqi Jin

Y

Yue Zhao

L

Lu Bai

Beijing Key Laboratory of Solid-State Battery and Energy Storage Process, Key Laboratory of Green Process and Engineering, State Key Laboratory of Mesoscience and Process Engineering

M

Mengyao Quan

Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China

X

Xiuzhu Qi

Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China

B

Bin Fu

State Key Laboratory of Medical Proteomics

Z

Zhigang Wu

Taizhou Research Institute

J

Jin Zhou

Department of Oncology Sichuan Cancer Hospital Chengdu China

H

Han Han

Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States

Z

Ziqi Wang

Division of Advanced Materials

S

Shiyu Wang

C

Chaoqiang Deng

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering Shanghai 200032 P. R. China

W

Weijian Sun

C

Cai Chang

Department of Ultrasound Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China

S

Shichong Zhou

H

Hongbo Zhang